Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,100
Closed -$396K 2651
2024
Q1
$396K Sell
18,100
-140,400
-89% -$3.01M ﹤0.01% 1963
2023
Q4
$3.69M Sell
158,500
-38,200
-19% -$769K 0.01% 954
2023
Q3
$3.88M Sell
196,700
-38,100
-16% -$750K 0.01% 866
2023
Q2
$5.32M Buy
234,800
+93,500
+66% +$1.88M 0.01% 746
2023
Q1
$2.78M Buy
141,300
+65,800
+87% +$1.26M 0.01% 1090
2022
Q4
$1.3M Buy
+75,500
New +$1.34M ﹤0.01% 1449

Other funds holding RXO

Two Sigma Advisers's RXO Position: Q2 2024 in Review

Two Sigma Advisers sold out of RXO (RXO) in Q2 2024, closing a stake of 18,100 shares — an estimated $396K sold.

Two Sigma Advisers first reported a position in RXO in Q4 2022 and held it in 6 quarters. The position peaked at $5.32M in Q2 2023. 243 funds tracked by Wall St. Rank hold RXO as of Q2 2024.

  • Two Sigma Advisers reported no remaining RXO position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 18,100 RXO shares in Q2 2024, an estimated $396K.
  • Two Sigma Advisers first reported a position in RXO in Q4 2022 and held it in 6 quarters.
  • Two Sigma Advisers's RXO position peaked at $5.32M in Q2 2023.
  • 243 funds tracked by Wall St. Rank held RXO as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.